cagrilintide clinical trials results Trial Scorecard: REDEFINE 1 and 2 Weight Loss Efficacy of Cagrilintide
Weight Loss Efficacy of Cagrilintide and Semaglutide gutsandgrowth Novo Nordisk's Cagrilintide shows promising weight loss in REDEFINE 1 sub analysis, unveiled at EASD 2025 Pharmacally Cagrilintide Weight Loss Results: What Patients in Louisiana Need to Know In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction Nature Reviews Gastroenterology & Hepatology Eloralintide vs. Cagrilintide vs. Petrelintide
Pay in 4 interest-free payments of $6.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





